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A nutritional placebo-controlled study was performed in Wistar rats in order to 
investigate the effects of  5-weeks aronia juice consumption towards fatty acid (FA) 
composition of  phospholipids in the plasma and liver, as well as plasma glucose (Glu) 
and cholesterol levels. The animals were divided into 3 groups of  8 animals each, and 
randomized to receive either the full polyphenol dose of  Aronia melanocarpa juice (AMJ), 
4 times less polyphenol dose (¼-AMJ) or polyphenol-lacking placebo beverage (PLB). 
Each group of  8 male adult Wistar rats received the liquid ad libitum. AMJ decreased 
the levels of  low-density lipoprotein (LDL) (P < 0.05) vs. PLB. AMJ increased dihomo-
γ-linoleic acid (DGLA, 20:3n-6) (P < 0.05) and decreased arachidonic acid content 
(AA, 20:4n-6) (P < 0.05) vs. PLB in liver phospholipids. AMJ signifi cantly increased 
monounsaturated fatty acids (MUFA) levels both in the liver (P < 0.05) and plasma (P < 
0.05). Both aronia juice doses elevated the levels of  benefi cial n-3 polyunsaturated fatty 
acids (PUFA) in the plasma and liver. There was a dose-dependent, signifi cant increase 
(P < 0.001) in cis-vaccenic acid (VA, 18:1n-7) in phospholipids in the plasma and liver. 
Our results indicate favorable effects of  aronia juice intake on lipid parameters in Wistar 
rats. These fi ndings suggest the potential of  aronia dietary intake in cardiometabolic 
diseases primary prevention strategies in the human population.
Key words: chokeberry, polyphenols, low-density lipoprotein, arachidonic acid, 
monounsaturated fatty acids
INTRODUCTION
Aronia melanocarpa (AM), a berry fruit, has been  scientifi cally investigated for a wide 
array of  health-promoting characteristics. The benefi cial properties of  AM on health 
are attributed to the high content of  non-nutritional phytochemicals i.e. polyphenols 
[1,2], both fl avonoid and non-fl avonoid subclasses. Benefi cial effects of  polyphenol 
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intake have been studied thoroughly [3,4], mostly in the context of  chronic disease 
prevention. 
Fatty acids (FA) are stored at different rates in different tissues [5,6], thus potentially 
infl uencing particular tissue metabolism. The phospholipid FA composition and 
cholesterol content are basic determinants of  the physical properties of  biomembranes. 
They have been  shown to infl uence a wide variety of  membrane dependent functions 
such as membrane transport, enzyme activity and receptor function [7]. The FA 
profi le in tissues partly refl ects not only the dietary fat intake, but also the effi ciency 
of  FA metabolism in the body [8]. The liver has an important role in the synthesis 
and metabolism of  phospholipids. Liver phospholipids are a building structure of  the 
hepatocyte membrane, they take part both in metabolic activities and repairing after 
metabolic disturbances [9].
Recently, rat animal models have been exploited for the investigation of  the protective 
effects of  consumption of  AM polyphenols towards the accumulation of  xenobiotics 
in soft animal tissues [10]. However, a limited number of  available studies deals with 
the biological effects of  AM consumption regarding cardio metabolic biomarkers in 
rats. Existing preclinical data indicate anti-oxidative [11,12], hypotensive [13], lipid-
lowering [1,14] and glucose-regulating [15] effects in rats treated with AMJ. There 
is a limited number of  studies dealing with the polyphenol-rich diet impact on lipid 
and FA status in rodent models [16,17]. So far, none of  the studies has investigated 
the biological effect of  polyphenols contained in AMJ towards FA tissue content in 
rats. In addition, none of  the available animal studies investigated the dose-response 
biological effects of  aronia juice towards the status of  phospholipids FA content in 
tissues. 
We challenged the benefi cial effects of  aronia juice long-term consumption in rats 
on phospholipid plasma and liver FA composition, as well as on some biochemical 
parameters. Additionally, we evaluated the dose-dependent effect of  consumption of  
aronia juice containing different polyphenol doses. 
MATERIALS AND METHODS
Study design and study treatments
The animals underwent a parallel, nutritional, placebo-controlled study. The animals 
were fed for 5-weeks with either one of  the 3 protocols: 2 doses of  aronia juice 
(“Nutrika”, Belgrade, Serbia), and PLB. PLB was synthesized to contain the exact 
nutritional values as aronia juice, including sugars, minerals and vitamins, but without 
bioactive polyphenols (N. Kardum, unpublished data). The aronia juice treatment was 
applied in 2 polyphenol doses: full polyphenol dose (AMJ) and a dose with exactly the 
same chemical composition as AMJ but with 4 times less polyphenol content (¼-AMJ). 
All of  the comparisons in the study were performed between animals receiving either 
of  2 polyphenol doses of  aronia juice versus control animals receiving the placebo.
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Characterization of the intervention treatments
Analysis of  phenolic compounds in AMJ was determined using a modifi ed Folin-
Ciocalteu method [18]. Beverage samples were diluted in distilled water to working 
solutions in order for absorbencies to fi t the standard calibration curve in the range 
of  0-600 μg/ml of  gallic acid. Results were expressed as micrograms of  gallic acid 
equivalents per ml of  beverage, and data are presented as mean ± SD for 3 replicates. 
The polyphenol content of  the study interventions is presented (Table 1) and quantities 
of  phenolic compounds in AMJ were presented by Tomić et al. [19]. 





Male, adult, 4-months old, Wistar rats, weighing 380–440 g, provided by the vivarium 
of  the Institute for Biological Research, Belgrade, Serbia, were used in this study. 
The animals were kept in groups of  4 per cage, under controlled conditions (room 
temperature 23–25°C, 12 h light–dark cycle, food and drinking liquid ad libitum). All 
animal procedures were in compliance with Directive 2010/63/EU on the protection 
of  animals used for experimental and other scientifi c purposes, and approved by the 
Ethical Committee for the Use of  Laboratory Animals of  the Institute for Biological 
Research “Siniša Stanković”, University of  Belgrade.
The animals were randomly assigned into 3 experimental groups of  8 animals each, to 
receive either AMJ, ¼-AMJ or PLB, supplied with 20% mixture (m/m) of  experimental 
beverage in tap water. Fresh drinking solutions were prepared daily. The rats were 
fed standard briquettes including a commercial non purifi ed diet (Veterinarski Zavod, 
Subotica, Serbia), containing (w/w) 20% protein, 40% carbohydrates, 5% fat, fi ber 
8%, and an adequate amount of  vitamins and minerals (ash 10%). 1 gram represented 
an estimated metabolic energy of  11 kJ with 17.09% derived from fat. The FA 
composition of  the supplied standard briquettes was: 18.91% SFA, 29.24% MUFA 
and 52.9% PUFA.
Experimental drinking solutions were offered ad libitum for 35 days. The body mass 
of  the rats was registered on days: -1, 7, 14, 21, 28 and 35, and presented as mean 
value ± SEM for each experimental group on the experiment weeks: 0-5 (Figure 
1a). There was no statistical difference between body mass of  animals between the 
different treatment groups on day -1 and before sacrifi ce on day 35 (P > 0.05 for 
both measurements, data not shown). Daily consumption of  drinking solutions was 
estimated for each group, and their average weekly consumption in ml of  solution per 
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animal/day are presented in Figure 1b. Food consumption per cage was estimated  3 
times a week and described as g of  food/animal/day of  every week of  the experiment 
(Figure 1c). According to the determined polyphenol content, we have calculated the 
daily average intake of  polyphenols to be 557.22 and 120.64 mg per ml of  treatment 
for AMJ and 1/4-AMJ groups, respectively (Figure 1d).
Sampling and biochemical analyses
On day 35 upon treatment, all animals were sacrifi ced by cardiac puncture under 
anesthesia, and blood samples were collected for biochemical and laboratory analysis. 
Blood samples (6–8 cm3) from all rats were collected by aorta abdominalis puncture 
in Na-citrate containing (3.8% w/v) tubes, and plasma samples were collected upon 
centrifugation. Liver samples  
were stored at -80°C. Biochemical parameters were determined from the plasma 
using standard laboratory kits on Cobas c-111 biochemical analyzer (Roche, Basel, 
Switzerland). 
Preparing liver tissue for phospholipids FA analysis and lipid extraction 
The liver tissue (1 g) was homogenized with a 2:1 chloroform/methanol mixture 
with butylated hydroxytoluene (BHT) as an antioxidant and washed with 5 times less 
Figure 1. Body mass and daily consumption. (a) changes in body mass; (b) consumption of  
either of  3 treatments; (c) food consumption; (d) daily polyphenol expenditure. The graphs 
are represented per3 groups of  animals (receiving either AMJ, ¼-AMJ or PLB) for (a), (b) and 
(c). The (d) is grouped per animals receiving either AMJ or ¼-AMJ treatment. All values are 
plotted as mean±SEM (a, b, c), and daily mean value (d)
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volume of  water. The resulting mixture separated into two phases, the lower phase 
yielding the total pure lipid extract. Further evacuation was done with 2:1 solvent 
systems: methanol/benzene, acetone/benzene, and ethanol/benzene. Upon adding 
and evacuation of  chloroform and adding hexane afterwards, samples were ready for 
thin layer chromatography (TLC) [20].
FA analysis in the liver tissue
The phospholipid fraction was isolated from the extracted lipids by one-dimensional 
TLC with the neutral lipid solvent system of  petrol ether-diethyl ether-acetic acid 
(87:12:1, v/v) using Silica Gel GF plates (C. Merck, Darmstadt, Germany). The 
extraction and preparation of  FA methyl esters and their gas chromatography analyses 
were performed as previously described [9]. Briefl y, FA methyl-ester derivatives formed 
from isolated plasma phospholipids fraction were separated by gas chromatography 
using Shimadzu GC 2014 (Shimadzu Co, Tokyo, Japan) equipped with a fl ame 
ionization detector and Rtx 2330 fused silica gel capillary column (60 m x 0.25 mm 
x 0.2 μm) (Restek Co, Bellefonte, PA, USA). The fl ame ionization detector was set at 
250°C, the injection port at 220°C, and the oven temperature programmed from 130 
to 190°C at heating rate of  3°C/min. Comparing sample peak retention times with 
authentic standards (Sigma Chemical Co, St. Louis, MO, USA) and/or the PUFA-2 
standard mixture (Supelco Inc., Belleforte, PA, USA), individual FA methyl esters were 
identifi ed [21].
Lipid extraction and plasma phospholipids FA analysis  
The total lipid extract was prepared by the method described by Folch [21]. The 
phospholipid fraction was isolated as indicated. The extraction and preparation of  
FA methyl esters and their gas chromatography analyses were performed as indicated. 
The identifi cation of  FA methyl esters was made by comparing sample peak retention 
times with authentic standards (PUFA-2 and/or 37 FAMEs mix, Supelco, Bellefonte, 
PA, USA) [22]. Finally, individual FA starting from palmitic acid (PA, 16:0) through 
docosahexaenoic acid (DHA, 22:6 n-3) were expressed as a percent in total identifi ed FA.
Statistical analysis  
The results are presented as mean ± SD. The differences between the groups 
were calculated by one-way Analyses of  Variance (One-way ANOVA) followed by 
Tukey’s Post Test of  individual signifi cant differences between the groups. Analysis 
was performed using the SPSS software (ver. 15.0; Chicago, IL), and the level of  
signifi cance was set at P < 0.05.
The sample size was calculated according to data on chokeberry effects on plasma 
cholesterol fractions content previously reported [23]. With statistical power set at 
80% (β = 0.80) and P value of  0.05, the required number of  animals was minimum 7 
per group.




LDL fraction was decreased in the group receiving  AMJ compared to the control 
group  receiving PLB (P = 0.021) (Table 2). 







TC [mmol/L] 0.91±0.09 1.05±0.10 0.96±0.17
Glu [mmol/L] 8.94±1.35 9.61±3.62 7.31±1.27
HDL [mmol/L] 0.78±0.08 0.72±0.09 0.70±0.10
LDL [mmol/L] 0.12±0.03 0.14±0.04 0.09±0.03*#
TAG [mmol/L] 0.72±0.14 0.96±0.16 0.99±0.44
Level of  signifi cant difference upon ANOVA. *compared to control group; #comparison between 
groups P <0.05. Data are presented as mean±SD. TC-total cholesterol; GLU-glucose; HDL-high-density 
lipoprotein; LDL-low-density lipoprotein; TAG-triglyceride.
The changes in plasma phospholipids FA composition
upon 5-weeks placebo-controlled aronia intervention 
There was a signifi cant, dose-dependent increase in plasma VA content in aronia-
receiving animals in comparison with PLB-receiving animals (P = 0.039, P = 0.003, 
for ¼-AMJ and AMJ, respectively). A statistically signifi cant increase was observed for 
total plasma MUFA in animals on either AMJ or ¼-AMJ, in comparison with  animals 
on PLB (Table 3), which was more pronounced in the AMJ group (P = 0.017), than 
in ¼-AMJ (P = 0.042). 








16:0 24.57 ± 0.76 24.25 ± 1.45 23.38 ± 1.49
18:0 22.06 ± 0.82 21.56 ± 1.48 21.79 ± 1.20
SFA 46.63 ± 0.83 45.80 ± 2.66 45.17 ± 2.18
16:1 0.43±0.06 0.46±0.12 0.41±0.15
18:1n-9 3.95±0.63 4.47±0.46 4.55±0.42
18:1n-7 2.66±0.22 3.34±0.48** 3.14±0.33*
MUFA 7.04±0.74 8.28±0.93* 8.10±0.76*
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cont. Table 3.
18:2n-6 21.75±1.38 22.38±1.65 21.05±1.76
20:3n-6 1.12±0.24 1.22±0.25 1.22±0.28
20:4n-6 16.89±1.60 15.48±0.98 17.14±1.52
20:5n-3 0.50±0.08 0.59±0.11 0.58±0.16
22:4n-6 0.41±0.06 0.41±0.17 0.50±0.11
22:5n-3 0.94±0.25 0.97±0.22 0.95±0.27
22:6n-3 4.71±0.72 4.80±0.93 5.29±0.36
PUFA 46.33±1.39 45.84±1.94 46.73±2.47
n-6 40.18±1.19 39.49±1.50 39.90±2.53
n-3 6.15±0.83 6.36±1.14 6.83±0.47
n-6/n-3 6.63±0.88 6.37±1.08 5.88±0.64
Omega-3-Index 5.21±0.75 5.39±1.03 5.88±0.40
AA/EPA 34.89±6.96 27.02±4.25 31.46±0.45
Level of  signifi cant difference upon ANOVA followed by Tukey’s Post Hoc multiple comparison test. 
*P <0.05; **P <0.01.Data are presented as % of  fatty acids in the total pool. SFA-total saturated fatty 
acids; MUFA-total monounsaturated fatty acids; PUFA-polyunsaturated fatty acids; Omega-3-Index-
EPA+DHA.
Changes in liver phospholipids FA composition
The same as for plasma phospholipids, the levels of  VA were signifi cantly increased in 
animals upon aronia juice exposure in a dose-dependent way, especially pronounced 
in the case of  AMJ (P = 0.001), in comparison with levels of  VA in control animals. 
Oleic acid (OA, 18:1n-9) followed the same increasing trend, which consequently led 
to a signifi cant increase in total MUFA levels in liver phospholipids (Table 4), again in 
a dose-dependent fashion, AMJ (P = 0.023) versus PLB. 
Upon polyphenol treatment there was a dose-dependent decrease in stearic acid (SA, 
18:0) in liver phospholipids (P = 0.01, P = 0.005, for ¼-AMJ and AMJ, respectively) 
compared to PLB treatment (Table 4).
Both aronia treatments increased the percentage of  docosapentaenoic acid (DPA, 
22:5n-3) (P = 0.076, P = 0.049, for AMJ and ¼-AMJ, respectively). Additionally, there 
was a signifi cant increase in n-3 PUFA (P = 0.053) upon AMJ treatment, compared to 
PLB treatment (Table 4).
In comparison with the control level, the level of  AA, upon 5-week consumption of  
AMJ was signifi cantly decreased (P = 0.05) in liver phospholipids (Table 4). Also, there 
was an increase in the percentage of  DGLA (P = 0.05) in AMJ group compared to 
PLB group (Table 4).
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16:0 19.91±0.57 20.52±0.91 21.01±1.21
18:0 22.24±0.93 20.70±0.51*** 20.78±0.88*
SFA 42.15±0.83 41.22±0.98 41.79±1.07
16:1 0.57±0.12 0.59±0.15 0.55±0.11
18:1n-9 3.10±0.50 3.19±0.29 3.19±0.34
18:1n-7 2.68±0.25 3.50±0.48*** 3.13±0.31
MUFA 6.35±0.57 7.29±0.72* 6.87±0.44
18:2n-6 15.99±1.85 16.33±0.96 16.59±1.09
20:3n-6 0.90±0.15 1.08±0.10* 1.01±0.14
20:4n-6 25.65±1.23 24.08±1.26* 24.06±1.02
20:5n-3 0.69±0.18 0.79±0.14 0.80±0.15
22:4n-6 0.27±0.02 0.30±0.03 0.26±0.03
22:5n-3 1.09±0.14 1.26±0.14* 1.28±0.12*
22:6n-3 7.26±0.63 7.64±0.54 7.34±0.39
PUFA 51.84±0.93 51.48±1.28 51.35±0.75
n-6 42.81±1.33 41.79±1.54 41.92±1.08
n-3 9.03±0.68 9.69±0.45* 9.43±0.43
n-6/n-3 4.77±0.47 4.32±0.33 4.46±0.30
Omega-3-Index 7.94±0.65 8.43±0.44 8.15±0.36
AA/EPA 40.15±12.68 31.42±6.93 31.08±7.60
Level of  signifi cant difference upon ANOVA followed by Tukey’s Post Hoc multiple comparison test. 
*P <0.05; **P <0.01; ***P <0.001. Data are presented as % of  fatty acids in the total pool. SFA-total 
saturated fatty acids; MUFA-total monounsaturated fatty acids; PUFA-polyunsaturated fatty acids; 
Omega-3-Index-EPA+DHA.
DISCUSSION
One of  the greatest advantages of  the study described herein is the application of  
an intermediate treatment dose. Three different treatments were applied (placebo 
beverage, and two doses of  aronia juice differing in polyphenol content) to three groups 
of  animals, thus enabling the evaluation of  a polyphenol dose-dependent effect on the 
lipid status. Our results indicated the favorable effect of  aronia juice consumption 
regarding lipid classes including LDL and FA phospholipids in the plasma and liver. 
The novelty of  this work is the investigation of  a dose-dependent biological effect 
of  polyphenol-rich aronia juice towards endogenous tissue phospholipid FA status in 
rats. 
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AMJ had a favorable decreasing effect on LDL level, while ¼-AMJ showed the 
opposite (Table 2). The exactly same trend, but without statistical signifi cance, was 
observed in Glu level upon treatment with two polyphenol doses of  aronia juice in 
comparison to the control. The hypocholesterolemic effect of  aronia polyphenols was 
previously demonstrated in rats with experimentally induced hyperlipidemia [1,23,24]. 
The hypoglycemic effect of  aronia incorporated into drinking water was observed in 
diabetic and normal rats upon intraperitoneal administration [25]. 
The postulated protective, lipid-lowering effects of  high polyphenol doses in AMJ, 
might account for the LDL decrease in the sub-cohort of  animals receiving AMJ. Qin 
and Anderson [15] have reported similar results, demonstrating a benefi cial metabolic 
shift in fructose fed rats receiving the aronia extract in comparison with those on the 
fructose diet solely.
Aronia juice consumption exerted a consistent biological effect on rat plasma and liver 
phospholipid FA profi les, upon 5-weeks of  aronia treatment. Upon treatment with 
both doses of  aronia juice, and in comparison with the control animals receiving PLB, 
there was an increase in OA, VA, and total MUFA levels, both in the plasma and liver. 
OA has anti-atherogenic and antithrombotic properties and increases HDL to LDL 
ratio. Incorporation of  OA into cholesterol esters, triglycerides and phospholipids of  
lipoprotein particles reduce lipoprotein oxidation. Incorporated into membrane lipids, 
OA regulates the fl uidity of  the cell membrane, the effi ciency of  transmembrane 
transport and affects signal transduction [26].
The dose-dependent increase in VA and MUFA levels was statistically signifi cant, 
which indicates the additive effect of  polyphenol content, in both tissues.
Studies dealing with the health implications of  cis-VA status are scarce. An interesting 
fi nding indicates an unfavorable association of  reduced levels of  VA in plasma and 
liver of  hypertensive rats with the incidence of  stroke-like metabolic features [27]. The 
inverse association of  cis-VA has been demonstrated in human studies investigating 
the correlation of  its content in red blood cells and plasma with the incidence of  
myocardial infarction and heart failure with antecedent coronary heart disease, 
respectively [28,29]. Accordingly, the current fi nding indicates the potentially favorable 
effect of  aronia juice through the elevation of  cis-VA plasma and liver content.
The decrease in SFA is dose/dependent in liver phospholipids, and may be indicative 
of  AMJ protective effects because long-chain SFA are speculated to induce pro-
infl ammatory responses [30] and apoptosis of  different vascular cell types [31].
The herein reported decrease in SFA in both tissues additionally indicates aronia-
protective effects, especially since it is coupled with the aronia-induced statistically 
signifi cant increase in MUFA levels, contemplated to be associated to benefi cial 
infl ammatory properties [32].
Also, DGLA that was increased in the liver upon AMJ treatment exert anti-
infl ammatory properties [33]. We have reported a dose-dependent decline in AA level, 
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in both tissues, that contributed to the dose-dependent decrease in overall n-6 PUFA. 
It is well known that AA is further metabolized to potent infl ammatory eicosanoids.
Additionally, both in the liver and plasma, there was an increase in EPA, DPA and 
DHA levels upon both polyphenol aronia doses, followed by a dose-dependent 
increase in total n-3 PUFA level, Omega-3-Index, as well as decrease in n-6/n-3 ratio. 
In contrast to n-6 PUFA, n-3 PUFA exert hypolipidemic, vasodilatory, antithrombotic, 
and anti-infl ammatory properties [34].
We demonstrated an increase in Omega-3-Index (EPA + DHA content) and a 
decrease in AA to EPA ratio upon aronia juice consumption. Since the Omega-3-
Index is inversely [35], and AA/EPA ratio directly associated with CVD risk [36], the 
results indicate additional aronia-juice cardio-protective effects.
Available exploratory preclinical research data on AM health effects [11-14] support 
our fi ndings. Thus, consumption of  aronia juice or chokeberry extract incorporated 
in the standard diet, has shown health-promoting properties in experimental rodent 
models, including rat models of  arterial hypertension [13], hyperlipidemia [1], 
metabolic syndrome [14], and glucose metabolic disorders which preferentially lead to 
diabetes [15]. Additionally, the pretreatment with aronia in laboratory rats has shown 
anti-oxidative effects in the case of  diet- [12,37] and chemically [11] induced oxidative 
stress. Observed benefi cial effects are attributed to the bioactivity of  polyphenols. We 
postulated a polyphenol dose-dependent cardio-protective effect in rats, through the 
balancing of  crucial fatty acid classes: increase in MUFA and n-3 PUFA levels, as well 
as an overall decline in the levels of  saturated fats. Possible background of  polyphenol 
bioactivity towards lipid metabolism is discussed in the available literature. In addition 
to the adipocyte cell cycle disruption, lipido-protective mechanisms for polyphenol 
dietary intake include several pathways: inhibition of  de novo lipogenesis, lipolysis 
promotion, fatty acid β-oxidation promotion, as well as different anti-infl ammatory 
mechanisms coupled with balancing of  intracellular and intra-tissue oxidative stress 
and insulin sensitivity improvement [38]. 
We concluded a dose-dependent benefi cial effect of  aronia juice consumption on 
LDL and plasma and liver phospholipids fatty acid profi les in aronia-treated Wistar 
rats. The implications from the current pre-clinical study in phospholipids FA profi les 
are to be confi rmed in large-scale clinical trials, encompassing both healthy and at-risk, 
disease-free populations. 
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EFEKAT ARONIJE (Aronia melanocarpa) NA MASNOKISELINSKI 
PROFIL FOSFOLIPIDA PLAZME I JETRE PACOVA WISTAR SOJA 
ZEC Manja, DEBELJAK MARTAČIĆ Jasmina, RANKOVIĆ Slavica, POKIMICA 
Biljana, TOMIĆ Mirko, IGNJATOVIĆ Đurđica, GLIBETIĆ Maria, POPOVIĆ 
Tamara
Na pacovima Wistar soja je uradjena nutritivna placebo-kontrolisana studija sa ciljem 
da se ispitaju efekti suplementacije sokom od aronije, u trajanju od pet nedelja, na 
masno-kiselinski profi l fosfolipida plazme i jetre, kao i na nivoe glukoze i holesterola 
u plazmi. Životinje su podeljene u tri grupe od po osam životinja. Životinje su ran-
domizirane tako da budu na jednom od tri tretmana: sok od aronije sa punom dozom 
polifenola (AMJ), sok od aronije sa četiri puta manjom dozom polifenola (1/4 AMJ) 
ili placebo (sok bez polifenola) (PLB). Svaka grupa odraslih mužjaka pacova Wis-
tar soja je dobijala tečnost ad libitum. AMJ tretman je uticao na sniženje nivoa lipo-
proteina niske gustine (LDL, P<0,05) u odnosu na PLB. AMJ tretman je uticao na 
povećanje dihomo-γ-linolenske kiseline (DGLA, 20:3n-6, P<0,05), kao i na smanjenje 
nivoa arahidonske kiseline (AA, 20:4n-6, P<0,05) u odnosu na placebo u fosfolipidima 
jetre. Tretman sokom od aronije sa visokom dozom polifenola je značajno povećao 
mononezasićene masne kiseline (MUFA), kako u fosfolipidima jetre (P<0,05), tako 
i u fosfolipidima plazme (P<0,05). Obe doze soka od aronije su značajno povećale 
nivo korisnih n-3 polinezasićenih masnih kiselina (PUFA) u plazmi i jetri. Uočeno je 
i dozno zavisno značajno povećanje cis-vakcenske kiseline (VA, 18:1n-7, P<0,001) u 
fosfolipidima plazme i jetre. Naši rezultati ukazuju na korisne efekte soka od aronije na 
lipidne parametre kod pacova Wistar soja. Ovakvi nalazi sugerišu mogućnost da unos 
soka od aronije može biti od koristi u strategijama primarne prevencije kardiovasku-
lanih oboljenja u humanoj populaciji.
